Skip to main content

QIAGEN announces plans to return approximately $250 million to shareholders via synthetic share repurchase proposal

By August 16, 2016News
qiagen logo

qiagen-logo

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced plans to return approximately $250 million to shareholders through a synthetic share repurchase proposal that combines a direct capital repayment with a reverse stock split.

These actions, which will lead to an adjustment in QIAGEN’s share capital, have been used previously by other large, multinational Dutch companies as an efficient way to provide returns to shareholders. The proposal, if adopted, is expected to be similar to QIAGEN repurchasing approximately $250 million of its own shares, but will enable the return of capital to all shareholders in a much faster and more efficient way than through a traditional open-market repurchase program.

{iframe}https://www.qiagen.com/us/about-us/press-releases/pressreleaseview?ID={48B284C1-4F8C-457E-ACB3-D5BA9489BB14}&lang=en{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.